Bayer

Bayer has strengthened its cardiovascular portfolio with a multi-million deal with Cytokinetics, despite ongoing legal issues and profit concerns...

Bayer announced new Climate FieldView features to help farmers transition from 2024 harvest to 2025 planning, enhancing understanding of seed, fertility, and crop protection impacts on yield...

On November 13, 2024, Bayer CropScience Limited reported Q2 FY 2024-25 revenue of ₹17,376 million and a profit before tax of ₹1,901 million, declaring an interim dividend of ₹90 per share...

On November 7, 2024, Bayer received FDA clearance for its MEDRAD® Centargo CT Injection System, enhancing workflow efficiency in radiology departments amid a US shortage of technologists...

Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. The company focuses on...